Citation Impact
Citing Papers
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
2010
Peroxynitrite-mediated inactivation of heme oxygenases
2004
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Pathogenic implications of iron accumulation in multiple sclerosis
2011
The heme synthesis and degradation pathways: role in oxidant sensitivity
2000
The molecular hallmarks of epigenetic control
2016 Standout
Albuminuria in Hematopoietic Cell Transplantation Patients: Prevalence, Clinical Associations, and Impact on Survival
2008
Cell Biology of Heme
1999
Nitric oxide the gatekeeper of endothelial vasomotor control
2008
A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
2011 StandoutNobel
Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice
2006
Advances in metal-induced oxidative stress and human disease
2011 Standout
Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment
1997
Modulation of oxidative stress as an anticancer strategy
2013 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Antisense therapeutics in oncology: current status
2014
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Increased expression of heme oxygenase-1 in human lung transplantation
2002
Heme oxygenase–carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?
1999
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Engineering interferons and interleukins for cancer immunotherapy
2022
The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis
1999
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Mechanisms of brain injury after intracerebral haemorrhage
2005 Standout
Heme Oxygenase-1 and Heat Shock Protein 70 Induction in Glia and Neurons throughout Rat Brain after Experimental Intracerebral Hemorrhage
1997
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Targeting the apoptosis pathway in hematologic malignancies
2013
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Intravascular hemolysis increases atherogenicity of diet-induced hypercholesterolemia in rabbits in spite of heme oxygenase-1 gene and protein induction
2001
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
2008
Acute respiratory distress syndrome
2019 Standout
Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury
2002
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Blood Radicals: Reactive Nitrogen Species, Reactive Oxygen Species, Transition Metal Ions, and the Vascular System
1996
The Heme-regulated Eukaryotic Initiation Factor 2α Kinase
2001
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Targeting gene expression to hypoxic tumor cells
1997 StandoutNobel
Radiation-Associated Kidney Injury
2010
In vitro cytotoxicity evaluation of graphene oxide from the peroxidase-like activity perspective
2016
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Hydrogen sulphide and its therapeutic potential
2007 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Effects of Interferon-γ and Lipopolysaccharide on Macrophage Iron Metabolism Are Mediated by Nitric Oxide-induced Degradation of Iron Regulatory Protein 2
2000
Induction of cyclo‐oxygenase‐2 in human endothelial cells by SIN‐1 in the absence of prostaglandin production
2001
Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions
2005
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
2002 Standout
Endogenous microRNA sponges: evidence and controversy
2016 Standout
Epigenetic Determinants of Cancer
2016
The therapeutic potential of carbon monoxide
2010 Standout
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
2005
Endothelial Cell Apoptosis Induced by Oxidized LDL Is Associated with the Down-regulation of the Cellular Caspase Inhibitor FLIP
1998
Strategies to improve radiotherapy with targeted drugs
2011
Interaction of heme oxygenase‐2 with nitric oxide donors
1999
Protein S-nitrosylation: purview and parameters
2005 Standout
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Expression of Heme Oxygenase in Human Airway Epithelial Cells
2001
Regulation of Heme Oxygenase-1 by Redox Signals Involving Nitric Oxide
2002
Modulation of Endothelial Cell Apoptosis by Heme Oxygenase-1-Derived Carbon Monoxide
2002
Physiology and Pathophysiology of Carnosine
2013 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Induction of ferritin and heme oxygenase-1 by endotoxin in the lung
1998
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
2014
Expression of heme oxygenase-1 in atherosclerotic lesions.
1998
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Recent developments in myelodysplastic syndromes
2014
Apoptosis: A Target for Anticancer Therapy
2018 Standout
Nitric oxide and the immune response
2001 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Antisense to LOX-1 Inhibits Oxidized LDL–Mediated Upregulation of Monocyte Chemoattractant Protein-1 and Monocyte Adhesion to Human Coronary Artery Endothelial Cells
2000 Standout
Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings
2016
Antiviral Actions of Interferons
2001 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease
1998
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Autocatalytic Radical Reactions in Physiological Prosthetic Heme Modification
2003
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
What Is Responsible for the Initiating Chemistry of Iron-Mediated Lipid Peroxidation: An Update
2007
Recent Advances in the Liquid-Phase Syntheses of Inorganic Nanoparticles
2004 Standout
Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease
2007
Heavy chain ferritin acts as an anti‐apoptotic gene that protects livers from ischemia‐reperfusion injury
2003
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury
2004
Metal–Organic Frameworks in Biomedicine
2011 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Multiple Myeloma
2011 Standout
Cross-Talk Between Iron Metabolism and Diabetes
2002
Glial brain tumor targeting of magnetite nanoparticles in rats
2001
Cell Biology of Heme
1999
Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS
2015
Attenuation of Some Metabolic Deteriorations Induced by Diabetes Mellitus Using Carnosine
2007
The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy.
1996
Iron overload diminishes atherosclerosis in apoE-deficient mice
2001
Works of Mark Juckett being referenced
Nitric oxide donors modulate ferritin and protect endothelium from oxidative injury
1996
Captopril to Mitigate Chronic Renal Failure After Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial
2007
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)
2013
Phase II Trial of Bevacizumab Combined with Low Dose Dexamethasone and Lenalidomide (BEV/REV/DEX) for Relapsed or Refractory Myeloma (MM).
2007
Comparison of the prognostic utility of the revised International Prognostic Scoring System and the F rench Prognostic Scoring System in azacitidine‐treated patients with myelodysplastic syndromes
2014
Azacitidine with or without Entinostat for the treatment of therapy‐related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
2015
444 GTB-3550 tri-specific killer engager TriKE™ drives NK cells expansion and cytotoxicity in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients
2021
Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo
1995
Heme and the Endothelium
1998
Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro.
1995
Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
2014